Lymphoma risk: Lymphoma is a very severe complication of primary Sjogren's
syndrome: 5 to 10%;bf patients followed for more than 10 years will develop
a lymphoma. Predictive factors include serum monoclonal immunoglobulins or
cryoglobulins and a B clone population in accessory salivary glands.
Typical clinical and histological presentation: Mucosal involvement (paroti
d as well as gastric or pulmonary localizations) is frequent According to t
he recent classification of lymphomas, most lymphomas developing in patient
s with Sjogren's syndrome are B lymphomas of the marginal zone: MALT lympho
mas or low-grade nodal monocytoid lymphomas which are sometimes not identif
ied until transformation to the giant cell stage.
Similarities with hepatitis C lymphomas: The pathophysiology of lymphoma in
Sjogren's syndrome remains unknown. To date, there is no argument favoring
a viral infection or a deregulation of a unique oncogene or anti-oncogene.
Certain similarities between lymphomas in Sjogren's syndrome and lymphomas
associated with hepatitic C virus would suggest a common pathogenisis: pos
sibly a permanent stimulation of auto-reactive B cells carrying a surface i
mmunoglobulin with rheumatoid factor activity in the target organs of the a
utoimmune disease.
These B lymphocytes would then proliferate secondarily.